Articles dans des revues avec comité de lecture (159)
1.
Dubois, N., Van Morckhoven, D., Tilleman, L., Van Nieuwerburgh, F., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2025). Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanism. HemaSphere.2.
Van Morckhoven, D., Dubois, N., Bron, D., Meuleman, N., Lagneaux, L., & Stamatopoulos, B. (2023). Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. Frontiers in immunology, 14, 1265969. doi:10.3389/fimmu.2023.12659693.
Otmani, K., Rouas, R., Lagneaux, L., Krayem, M., Duvillier, H., Berehab, M., & Lewalle, P. (2023). Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways. Cell Communication and Signaling, 21(1), 253. doi:10.1186/s12964-023-01259-14.
Draguet, F., Dubois, N., Bouland, C., Pieters, K., Bron, D., Meuleman, N., Stamatopoulos, B., & Lagneaux, L. (2023). Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells. Cancers, 15(11), 2901. doi:10.3390/cancers151129015.
Draguet, F., Bouland, C., Dubois, N., Bron, D., Meuleman, N., Stamatopoulos, B., & Lagneaux, L. (2023). Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review. Pharmaceutics, 15(2). doi:10.3390/pharmaceutics150205586.
Massaro, F., Corrillon, F., Stamatopoulos, B., Dubois, N., Ruer, A., Meuleman, N., Bron, D., & Lagneaux, L. (2023). Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression. Frontiers in immunology, 14, 1267550. doi:10.3389/fimmu.2023.12675507.
Maene, A., Deniz, G., Bouland, C., Lagneaux, L., Philippart, P., & Buxant, F. (2022). Suburethral implantation of autologous regenerative cells for female stress urinary incontinence management: Results of a pilot study. European journal of obstetrics, gynecology, and reproductive biology, 278, 38-44. doi:10.1016/j.ejogrb.2022.08.0288.
Bouhtit, F., Najar, M., Rahmani, S., Melki, R., Najimi, M., Sadki, K., Boukhatem, N., Twizere, J.-C., Meuleman, N., Lewalle, P., Lagneaux, L., & Merimi, M. (2022). Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases. Inflammation research, 71(7-8), 887-898. doi:10.1007/s00011-022-01573-39.
Najar, M., Melki, R., Khalife, F., Lagneaux, L., Bouhtit, F., Moussa Agha, D., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Merimi, M. (2022). Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Frontiers in Cell and Developmental Biology, 9, 716853. doi:10.3389/fcell.2021.71685310.
Najar, M., Merimi, M., Faour, W. H., Lombard, C. A., Moussa Agha, D., Ouhaddi, Y., Sokal, E. M., Lagneaux, L., & Fahmi, H. (2021). In Vitro Cellular and Molecular Interplay between Human Foreskin-Derived Mesenchymal Stromal/Stem Cells and the Th17 Cell Pathway. Pharmaceutics, 13(10). doi:10.3390/pharmaceutics1310173611.
Merimi, M., El-Majzoub, R., Lagneaux, L., Moussa Agha, D., Bouhtit, F., Meuleman, N., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Najar, M. (2021). The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.66153212.
Merimi, M., Buyl, K., Daassi, D., Rodrigues, R. M., Melki, R., Lewalle, P., Vanhaecke, T., Fahmi, H., Rogiers, V., Lagneaux, L., De Kock, J., & Najar, M. (2021). Transcriptional profile of cytokines, regulatory mediators and tlr in mesenchymal stromal cells after inflammatory signaling and cell-passaging. International journal of molecular sciences, 22(14), 7309. doi:10.3390/ijms22147309